iptimestamppersonemailpgidpaperalleletransgenecaused_byrnai genernai reagentspeciespersonalphenotypenotphenotype remarksuggested definitionnaturefuncpenetranceheat_senscold_sensgenotypestraincomment
50.19.229.2292026-01-09 11:22:16WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6410940627529 (WBPaper00068325)wa17 (WBVar00275123)membrane fluidity variant (WBPhenotype:0002484)Figure 2, mutants have rigid membranes
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411040627529 (WBPaper00068325)wa17 (WBVar00275123)slow growth (WBPhenotype:0000031)
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411140627529 (WBPaper00068325)wa17 (WBVar00275123)lipid composition variant (WBPhenotype:0000138)Fig 3, mutants have reduced UFA levels
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411240627529 (WBPaper00068325)wa17 (WBVar00275123)mitochondrial stress response variant (WBPhenotype:0002434)Fig 8, mutants have increased hsp-60::gfp signal
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411340627529 (WBPaper00068325)wa17 (WBVar00275123)ER stress response variant (WBPhenotype:0001485)Fig 8, mutants have increased hsp-4::gfp signal
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411440627529 (WBPaper00068325)wa17 (WBVar00275123)cell stress response variant (WBPhenotype:0000142)Fig 8, mutants have abnormal DAF-16::gfp localization
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411540627529 (WBPaper00068325)wa17 (WBVar00275123)diet response variant (WBPhenotype:0002525)Fig 2, mutant growth is rescued by dietary PUFAs
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411640627529 (WBPaper00068325)wa17 (WBVar00275123)lipid composition variant (WBPhenotype:0000138)Fig 4, mutants have high lipid abundance seen by Oil Red O staining
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411740627529 (WBPaper00068325)wa17 (WBVar00275123)protein expression reduced (WBPhenotype:0000120)Fig 6, expression of HIF-1 in fat-2(wa17) mutant is decreased in western blot
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411840627529 (WBPaper00068325)wa17 (WBVar00275123)protein expression reduced (WBPhenotype:0000120)Fig 6, expression of FAT-2 is reduced in wa17 mutant
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6411940627529 (WBPaper00068325)wa17 (WBVar00275123)diet response variant (WBPhenotype:0002525)Fig 9, mutant growth increased by supplementation with ferric ammonium citrate and paraquat
50.19.229.2292026-01-09 11:50:29WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412040627529 (WBPaper00068325)wa17 (WBVar00275123)hypoxia response variant (WBPhenotype:0002423)NOTFig 9, mutant growth increased by short hypoxia exposure
50.19.229.2292026-01-09 12:40:55WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412140627529 (WBPaper00068325)et60 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppressor of fat-2(wa17) growth defect
50.19.229.2292026-01-09 12:40:55WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412240627529 (WBPaper00068325)et60 (no match)protein expression increased (WBPhenotype:0000119)Fig 6, expression of HIF-1 increased in fat-2(wa17);egl-9(et60) double mutant
50.19.229.2292026-01-09 12:40:55WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412340627529 (WBPaper00068325)et60 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7, suppressor of fat-2(wa17) PUFA shortage
50.19.229.2292026-01-09 12:43:15WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412440627529 (WBPaper00068325)et61 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:43:15WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412540627529 (WBPaper00068325)et61 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7, suppressor of fat-2(wa17) PUFA shortage
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412640627529 (WBPaper00068325)et62 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412740627529 (WBPaper00068325)et63 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412840627529 (WBPaper00068325)et64 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6412940627529 (WBPaper00068325)et65 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413040627529 (WBPaper00068325)et62 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7, suppressor of fat-2(wa17) PUFA shortage
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413140627529 (WBPaper00068325)et63 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7, suppressor of fat-2(wa17) PUFA shortage
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413240627529 (WBPaper00068325)et64 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7, suppressor of fat-2(wa17) PUFA shortage
50.19.229.2292026-01-09 12:45:19WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413340627529 (WBPaper00068325)et65 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7, suppressor of fat-2(wa17) PUFA shortage
50.19.229.2292026-01-09 12:47:30WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413440627529 (WBPaper00068325)et62 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:47:30WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413540627529 (WBPaper00068325)et63 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:47:30WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413640627529 (WBPaper00068325)et64 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:47:30WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413740627529 (WBPaper00068325)et65 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:48:27WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413840627529 (WBPaper00068325)et66 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:48:27WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6413940627529 (WBPaper00068325)et67 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:48:27WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414040627529 (WBPaper00068325)et68 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 12:48:27WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414140627529 (WBPaper00068325)et69 (no match)growth variant (WBPhenotype:0000030)Fig 5, suppresses growth defect of fat-2(wa17)
50.19.229.2292026-01-09 13:11:34WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414240627529 (WBPaper00068325)et65 (no match)protein expression variant (WBPhenotype:0000112)Fig 6. et65 increases FAT-2 protein expression of the near-null fat-2(wa17) mutant
50.19.229.2292026-01-09 13:11:34WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414340627529 (WBPaper00068325)et65 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7. fat-2(wa17) fat-2 (et65) double mutant has reduced MUFA levels and increased PUFA levels relative to fat-2(wa17) single mutant. In particular the double mutant has increased levels of EPA (20:5)
50.19.229.2292026-01-09 13:16:12WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414440627529 (WBPaper00068325)et68 (no match)protein expression reduced (WBPhenotype:0000120)Fig 6. ftn-2(et68);fat-2(wa17) double mutant has reduced expression of HIF-1 relative to WT
50.19.229.2292026-01-09 13:16:12WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414540627529 (WBPaper00068325)et68 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7. et68 increases the levels of EPA (20:5) in the fat-2(wa17) mutant
50.19.229.2292026-01-09 13:16:12WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414640627529 (WBPaper00068325)et68 (no match)protein expression increased (WBPhenotype:0000119)Fig 6. Expression of FAT-2 is increased in the ftn-2(et68);fat-2(wa17) mutant relative to fat-2(wa17)
50.19.229.2292026-01-09 13:19:21WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414740627529 (WBPaper00068325)et69 (no match)protein expression reduced (WBPhenotype:0000120)Fig 6. fat-2(wa17);hif-1(et69) double mutant has reduced expression of FAT-2 relative to WT
50.19.229.2292026-01-09 13:19:21WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414840627529 (WBPaper00068325)et69 (no match)lipid composition variant (WBPhenotype:0000138)Fig 7. et69 increases the levels of EPA (20:5) in the fat-2(wa17) mutant
50.19.229.2292026-01-09 13:19:21WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6414940627529 (WBPaper00068325)et69 (no match)mRNA expression variant (WBPhenotype:0000114)Fig 6. et69 had reduced FTN-2 mRNA expression relative to WT
50.19.229.2292026-01-09 13:35:14WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6415040627529 (WBPaper00068325)et68 (no match)membrane fluidity variant (WBPhenotype:0002484)Fig 8. et68 suppressed the membrane rigidity phenotype of the fat-2(wa17) mutant
50.19.229.2292026-01-09 13:35:14WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6415140627529 (WBPaper00068325)et68 (no match)mitochondrial stress response variant (WBPhenotype:0002434)Fig 8. et68 suppresses mitochondrial stress response of fat-2(wa17)
50.19.229.2292026-01-09 13:35:14WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6415240627529 (WBPaper00068325)et68 (no match)cell stress response variant (WBPhenotype:0000142)Fig 8. et68 normalizes abnormal DAF-16::gfp localization of fat-2(wa17)
50.19.229.2292026-01-09 13:35:14WBPerson54927 (Delaney Kaper)delaney.kaper@gu.se6415340627529 (WBPaper00068325)et68 (no match)ER stress response variant (WBPhenotype:0001485)Fig 8. et68 suppresses the ER stress response of fat-2(wa17)
50.19.229.2292026-01-19 10:18:07WBPerson19299 (Janine Kirstein)janine.kirstein@uni-jena.de6724440663102 (WBPaper00068359)nra-4 (WBGene00015344)AhringerCaenorhabditis elegansthrashing reduced (WBPhenotype:0000273)
50.19.229.2292026-01-20 12:16:20WBPerson7811 (Chisato Ushida)cushida@hirosaki-u.ac.jp6415440664083 (WBPaper00068345)n5007 (no match)egg laying variant (WBPhenotype:0000640)
50.19.229.2292026-01-22 8:40:52WBPerson49627 (Han-Wen Chang)v8513049021488@gmail.com6415540591707 (WBPaper00068496)yph413 (no match)hypoosmotic shock hypersensitive (WBPhenotype:0000554)
50.19.229.2292026-01-24 22:35:34WBPerson55385 (Inna A Nikonorova)nikonoi1@hginj.rutgers.edu6415640180912 (WBPaper00068838)tm12580 (WBVar02150155)male mating defective (WBPhenotype:0001414)Figure 7B
3.89.84.2512026-02-05 4:51:52WBPerson14810 (Chun-Hao Chen)chunhaochen@ntu.edu.tw6415741174260 (WBPaper00068766)e1370 (WBVar00143949)sexually dimorphic morphology variant (WBPhenotype:0001023)
3.89.84.2512026-02-15 19:37:59WBPerson70213 (John J McCarthy)jjmcca2@uky.edu6415840490136 (WBPaper00068244)n4102 (WBVar00090792)swimming variant (WBPhenotype:0001700) Locomotion analysis of worm movement showed that Untrained mir-1 mutant worms had poorer swim performance parameters, including significantly lower wave initiation rate (Figure 1I) and significantly lower activity index compared to Untrained N2 worms (Figure 1J). Following the 5-day exercise protocol, wave initiation rate and activity index were significantly higher in N2 worms compared to Untrained N2 worms (Figures 1K-L). The mir-1 mutant worms did not show a significant change in these exercise performance parameters in response to training compared to Untrained mir-1 mutant worms.
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6415940832700 (WBPaper00068545)jj321 (WBVar02160696)egg laying defective (WBPhenotype:0000006)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416040832700 (WBPaper00068545)jj471 (WBVar02160694)egg laying defective (WBPhenotype:0000006)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416140832700 (WBPaper00068545)jj473 (WBVar02160695)egg laying defective (WBPhenotype:0000006)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416240832700 (WBPaper00068545)jj321 (WBVar02160696)bivulva (WBPhenotype:0002011)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416340832700 (WBPaper00068545)jj471 (WBVar02160694)bivulva (WBPhenotype:0002011)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416440832700 (WBPaper00068545)jj473 (WBVar02160695)bivulva (WBPhenotype:0002011)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416540832700 (WBPaper00068545)jj321 (WBVar02160696)constipated (WBPhenotype:0000651)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416640832700 (WBPaper00068545)jj471 (WBVar02160694)constipated (WBPhenotype:0000651)
3.89.84.2512026-02-16 20:59:06WBPerson1659 (Jun Kelly Liu)kelly.jun.liu@cornell.edu6416740832700 (WBPaper00068545)jj473 (WBVar02160695)constipated (WBPhenotype:0000651)
3.89.84.2512026-03-10 14:12:21WBPerson1950 (Verena Jantsch)verena.jantsch@univie.ac.at6416841290579 (WBPaper00068860)syb2608 (no match)embryonic lethal (WBPhenotype:0000050)
3.89.84.2512026-03-10 14:14:10WBPerson1950 (Verena Jantsch)verena.jantsch@univie.ac.at6416941290579 (WBPaper00068860)jf216 (no match)embryonic lethal (WBPhenotype:0000050)
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417041863028 (WBPaper00069306)tm2112 (WBVar00251052)touch resistant tail (WBPhenotype:0000316)
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417141863028 (WBPaper00069306)tm2112 (WBVar00251052)pharyngeal pumping variant (WBPhenotype:0000634)NOT
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417241863028 (WBPaper00069306)tm2112 (WBVar00251052)body bend variant (WBPhenotype:0001703)NOT
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417341863028 (WBPaper00069306)tm2112 (WBVar00251052)nose touch variant (WBPhenotype:0004026)NOT
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417441863028 (WBPaper00069306)tm2112 (WBVar00251052)touch resistant anterior body (WBPhenotype:0000850)NOT
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417541863028 (WBPaper00069306)tm2112 (WBVar00251052)forward locomotion variant (WBPhenotype:0002345)NOT
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417641863028 (WBPaper00069306)tm2112 (WBVar00251052)backward locomotion variant (WBPhenotype:0001005)NOT
3.89.84.2512026-03-24 6:28:44WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417741863028 (WBPaper00069306)tm2112 (WBVar00251052)reversal variant (WBPhenotype:0002320)NOT
3.89.84.2512026-03-24 6:31:29WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417841863028 (WBPaper00069306)tm2112 (WBVar00251052)long defecation cycle (WBPhenotype:0000208)Heat Sensitive
3.89.84.2512026-03-24 6:31:29WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6417941863028 (WBPaper00069306)tm2112 (WBVar00251052)expulsion defective (WBPhenotype:0000996)Heat Sensitive
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418041863028 (WBPaper00069306)tm1989 (WBVar00250949)forward locomotion increased (WBPhenotype:0002346)
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418141863028 (WBPaper00069306)tm1989 (WBVar00250949)reduced frequency of spontaneous reversal initiation (WBPhenotype:0002602)
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418241863028 (WBPaper00069306)tm1989 (WBVar00250949)pharyngeal pumping variant (WBPhenotype:0000634)NOT
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418341863028 (WBPaper00069306)tm1989 (WBVar00250949)body bend variant (WBPhenotype:0001703)NOT
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418441863028 (WBPaper00069306)tm1989 (WBVar00250949)defecation variant (WBPhenotype:0000650)NOT
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418541863028 (WBPaper00069306)tm1989 (WBVar00250949)nose touch variant (WBPhenotype:0004026)NOT
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418641863028 (WBPaper00069306)tm1989 (WBVar00250949)touch resistant anterior body (WBPhenotype:0000850)NOT
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418741863028 (WBPaper00069306)tm1989 (WBVar00250949)touch resistant tail (WBPhenotype:0000316)NOT
3.89.84.2512026-03-24 6:35:33WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418841863028 (WBPaper00069306)tm1989 (WBVar00250949)backward locomotion variant (WBPhenotype:0001005)NOT
3.89.84.2512026-03-24 6:42:52WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6418932855271 (WBPaper00060161)tm1988 (WBVar00250948)spontaneous reversal variant (WBPhenotype:0001505)
3.89.84.2512026-03-24 6:42:52WBPerson11867 (Yasuaki Saitoh)saitohy@pharm.kitasato-u.ac.jp6419032855271 (WBPaper00060161)tm1988 (WBVar00250948)body bend variant (WBPhenotype:0001703)NOT
3.89.84.2512026-03-30 6:30:09WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419141214214 (WBPaper00068794)gk3094 (WBVar00601112)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants.
3.89.84.2512026-03-30 6:30:09WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419241214214 (WBPaper00068794)qm150 (WBVar00241264)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants.
3.89.84.2512026-03-30 6:30:09WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419341214214 (WBPaper00068794)km4 (WBVar00088241)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants.
3.89.84.2512026-03-30 6:30:09WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419441214214 (WBPaper00068794)zj15 (WBVar02145368)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants.
3.89.84.2512026-03-30 6:34:38WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419541214214 (WBPaper00068794)tm1978 (WBVar00250938)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants
3.89.84.2512026-03-30 6:34:38WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419641214214 (WBPaper00068794)zj15 (WBVar02145368)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants
3.89.84.2512026-03-30 6:34:38WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419741214214 (WBPaper00068794)km4 (WBVar00088241)diet induced life span variant (WBPhenotype:0001837)E.coli diets that induce oxidative stress and reduce FAT-7 expression in worms do not increase the lifespan of these mutants
3.89.84.2512026-03-30 6:34:38WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419841214214 (WBPaper00068794)tm1978 (WBVar00250938)drug induced life span variant (WBPhenotype:0001871)Bipyridyl supplementation do not increase lifespan of these mutants.
3.89.84.2512026-03-30 6:34:38WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6419941214214 (WBPaper00068794)zj15 (WBVar02145368)drug induced life span variant (WBPhenotype:0001871)Bipyridyl supplementation do not increase lifespan of these mutants.
3.89.84.2512026-03-30 6:34:38WBPerson58121 (Priyanka Das)ph21007@iisermohali.ac.in6420041214214 (WBPaper00068794)km4 (WBVar00088241)drug induced life span variant (WBPhenotype:0001871)Bipyridyl supplementation do not increase lifespan of these mutants.
3.89.84.2512026-04-01 19:50:27WBPerson58652 (Aeowynn J Coakley)acoakley@usc.edu6420141286443 (WBPaper00068868)n3247 (WBVar00090673)life span phenotype (WBPhenotype:0000039)NOTDisplays no lifespan extension or reduction as compared to N2 control. To further assess whether the beneficial effects of octopaminergic xbp-1s animals are mediated through nonautonomous signaling similar to other neuronal paradigms, we next measured lifespan in a mutant for octopamine signaling. A loss of function mutation of the gene encoding the tyramine beta-hydroxylase enzyme required for octopamine synthesis, tbh-1(n3247), fully suppressed the lifespan extension of octopaminergic xbp-1s animals (Fig. 3F).
3.89.84.2512026-04-01 19:55:04WBPerson58652 (Aeowynn J Coakley)acoakley@usc.edu6420241286443 (WBPaper00068868)zc12 (WBVar00275455)life span phenotype (WBPhenotype:0000039)NOTDisplays no significant lifespan extension or reduction as compared to N2 control, see Figure 3E.
3.89.84.2512026-04-02 11:47:39WBPerson715 (Monique Zetka)monique.zetka@mcgill.ca6420341136395 (WBPaper00068729)vv153 (no match)autosomal nondisjunction meiosis (WBPhenotype:0000206)
3.89.84.2512026-04-06 14:43:26WBPerson62243 (Rehab Salama)rasalama@wpi.edu64204PMC12393455 (no match)nch012 (no match)wing cilia morphology variant (WBPhenotype:0001248)
3.89.84.2512026-04-06 14:43:26WBPerson62243 (Rehab Salama)rasalama@wpi.edu64205PMC12393455 (no match)nch012 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)
3.89.84.2512026-04-06 14:47:42WBPerson62243 (Rehab Salama)rasalama@wpi.edu64206PMC12393455 (no match)nch011 (no match)wing cilia morphology variant (WBPhenotype:0001248)
3.89.84.2512026-04-06 14:47:42WBPerson62243 (Rehab Salama)rasalama@wpi.edu64207PMC12393455 (no match)nch011 (no match)osmotic avoidance defective (WBPhenotype:0000249)
3.89.84.2512026-04-06 14:47:42WBPerson62243 (Rehab Salama)rasalama@wpi.edu64208PMC12393455 (no match)nch011 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 14:50:41WBPerson62243 (Rehab Salama)rasalama@wpi.edu64209PMC12393455 (no match)nch009 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)
3.89.84.2512026-04-06 14:50:41WBPerson62243 (Rehab Salama)rasalama@wpi.edu64210PMC12393455 (no match)nch009 (no match)wing cilia morphology variant (WBPhenotype:0001248)
3.89.84.2512026-04-06 14:52:14WBPerson62243 (Rehab Salama)rasalama@wpi.edu64211PMC12393455 (no match)nch010 (no match)wing cilia morphology variant (WBPhenotype:0001248)
3.89.84.2512026-04-06 14:52:14WBPerson62243 (Rehab Salama)rasalama@wpi.edu64212PMC12393455 (no match)nch010 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)
3.89.84.2512026-04-06 15:03:27WBPerson62243 (Rehab Salama)rasalama@wpi.edu64213PMC12393455 (no match)nch004 (no match)AWC odorant chemotaxis variant (WBPhenotype:0001467)NOT
3.89.84.2512026-04-06 15:03:27WBPerson62243 (Rehab Salama)rasalama@wpi.edu64214PMC12393455 (no match)nch004 (no match)wing cilia morphology variant (WBPhenotype:0001248)NOT
3.89.84.2512026-04-06 15:05:52WBPerson62243 (Rehab Salama)rasalama@wpi.edu64215PMC12393455 (no match)nch004 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 15:05:54WBPerson62243 (Rehab Salama)rasalama@wpi.edu64216PMC12393455 (no match)nch004 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 15:05:57WBPerson62243 (Rehab Salama)rasalama@wpi.edu64217PMC12393455 (no match)nch004 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 15:06:01WBPerson62243 (Rehab Salama)rasalama@wpi.edu64218PMC12393455 (no match)nch004 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 15:07:13WBPerson62243 (Rehab Salama)rasalama@wpi.edu64219PMC12393455 (no match)nch004 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 15:07:13WBPerson62243 (Rehab Salama)rasalama@wpi.edu64220PMC12393455 (no match)nch004 (no match)wing cilia morphology variant (WBPhenotype:0001248)NOT
3.89.84.2512026-04-06 15:09:28WBPerson62243 (Rehab Salama)rasalama@wpi.edu64221PMC12393455 (no match)nch005 (no match)AWC odorant chemotaxis defective (WBPhenotype:0001060)NOT
3.89.84.2512026-04-06 15:09:28WBPerson62243 (Rehab Salama)rasalama@wpi.edu64222PMC12393455 (no match)nch005 (no match)wing cilia morphology variant (WBPhenotype:0001248)NOT